TCL Archive Cancer Policy: NCAB Recommends Mammograms Every 1 to 2 Years for Average Risk Women 40-49 April 4, 1997
TCL Archive Trastuzumab Showed Improved Survival In Stage IV Breast Cancer with CNS Metastases August 26, 2011
TCL Archive New benchmark for CCSG award funding will be lowered from 20 percent of NCI research base to 15 percent, the program’s “reality ratio,” Karen Antman tells NCAB. October 8, 2004
TCL Archive In Brief: Friedman Named FDA Deputy Commissioner; Parkinson To Lead CTEP; Walsh Resigns September 22, 1995
TCL Archive News Analysis: The Political Economy of Importation to Alleviate Cancer Drug Shortages March 2, 2012
